Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Gelnhausen

13 clinical trials in Gelnhausen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Gelnhausen at a glance
13
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

13 trials in Gelnhausen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Hypercholesterolaemia

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Gelnhausen

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and management of cardiovascular disease, exploring new therapeutic combinations and interventions for improved patient outcomes.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Lipoprotein Studies

Research includes evaluation of novel drug combinations and targeted therapies for reducing major cardiovascular events.

02 Metabolic Disorders

Comprehensive research into Type 2 Diabetes management, investigating new treatment approaches and comparing effectiveness of different therapeutic options.

  • Diabetes Management
  • Blood Sugar Control
  • Long-term Treatment Outcomes

Studies focus on innovative medications and their impact on glycemic control and cardiovascular outcomes.

03 Weight Management & Metabolism

Integrated research addressing obesity and metabolic health, with particular attention to patients with multiple conditions including diabetes and cardiovascular risks.

  • Obesity Treatment
  • Weight Management
  • Cholesterol Control

Trials examine new therapeutic approaches for weight management and metabolic improvement in complex patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.